ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
Hiukka, A., Stahlman, M., Pettersson, C., Levin, M., Adiels, M., Teneberg, S., Leinonen, E. S., Hulten, L. M., Wiklund, O., Oresic, M., Olofsson, S.-O., Taskinen, M.-R., Ekroos, K., Boren, J.Volume:
58
Language:
english
Journal:
Diabetes
DOI:
10.2337/db09-0206
Date:
September, 2009
File:
PDF, 797 KB
english, 2009